Announcements Trials
Browse Landscape

Status

Completed 39Unknown 19Recruiting 7Terminated 4Not yet recruiting 4Active not recruiting 4Enrolling by invitation 1

Sponsor Class

OTHER 4

Study Type

Interventional 249Observational 4

Sponsor

Cancer Type

Breast 2Tumor-Agnostic 1Thoracic 1Genitourinary 1Gastrointestinal 1

Conditions

Breast Neoplasms 2Neoplasms 1Liver Neoplasms 1Hypertension 1Colorectal Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Blood Specimen Collection 27Surveys and Questionnaires 24Magnetic Resonance Spectroscopy 10Observation 7Flow Cytometry 7Specimen Handling 6Amplified Fragment Length Polymorphism Analysis 6exemestane 5Radiotherapy 5Magnetic Resonance Imaging 5Immunoenzyme Techniques 5Biopsy 5Radiation 4Neoadjuvant Therapy 4Mental Status and Dementia Tests 4Genetic Testing 4Gene Expression Profiling 4Electroporation 4Data Collection 4Bevacizumab 4Trastuzumab 3Tomography, X-Ray Computed 3Tomography, Optical Coherence 3Therapeutics 3Surgical Procedures, Operative 3Sunitinib 3Sorafenib 3Registries 3Radiosurgery 3Psychiatric Rehabilitation 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × Observational × Bevacizumab × Clear all
NCT02420509 2025-06-04

Postoperative Chemotherapy in High-Grade Appendiceal Adenocarcinoma With Peritoneal Carcinomatosis

University of California, San Diego

Terminated
2 enrolled
Tumor-Agnostic

Neoplasms

NCT00537173 2017-01-25

Predicting Response and Toxicity in Patients Receiving Paclitaxel and Avastin for Breast Cancer

Hoosier Cancer Research Network

Terminated
11 enrolled
Breast

Breast Neoplasms

NCT01507740 2015-04-29

Profile of Soluble and Cellular Biomarkers and of Functional Imaging During Antiangiogenic Therapies in Cancer Patients

Medical University Innsbruck

Terminated
60 enrolled
GastrointestinalGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Liver Neoplasms, Colorectal Neoplasms

NCT00674011 2014-05-06

Hypertension in Breast Cancer Patients Receiving Bevacizumab

Dana-Farber Cancer Institute

Terminated
10 enrolled
Breast

Breast Neoplasms, Hypertension

Data powered by HemOnc (CC BY 4.0) Colophon âš¡